Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy

BACKGROUND: EPIC1 is an oncogenic long non-coding ribonucleic acid (RNA) that promotes cell growth and cell-cycle progression and inhibits apoptosis in several cancer cell lines. However, clinical studies on EPIC1 in breast cancer, specifically in the neoadjuvant setting, are relatively few. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yaqian, Wang, Yan, Yuan, Chenwei, Sheng, Xiaonan, Sha, Rui, Dai, Huijuan, Zhang, Shan, Wang, Yaohui, Lin, Yanping, Zhou, Liheng, Xu, Shuguang, Zhang, Jie, Yin, Wenjin, Lu, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383657/
https://www.ncbi.nlm.nih.gov/pubmed/32782487
http://dx.doi.org/10.1177/1758835920940886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383657/
https://www.ncbi.nlm.nih.gov/pubmed/32782487
http://dx.doi.org/10.1177/1758835920940886

Ejemplares similares